Who Exports Doxorubicin from India — 310 Suppliers Behind a $67.3M Market
India's doxorubicin export market is supplied by 310 active exporters who collectively shipped $67.3M across 3,492 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 52.2% market share, followed by DR.REDDY'S LABORATORIES LTD and FRESENIUS KABI ONCOLOGY LIMITED. The top 5 suppliers together control 77.9% of total export value, reflecting a concentrated market structure.
Top Doxorubicin Exporters from India — Ranked by Export Value
SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading doxorubicin exporter from India, holding a 52.2% share of the $67.3M market across 3,492 shipments from 310 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, DR.REDDY'S LABORATORIES LTD, FRESENIUS KABI ONCOLOGY LIMITED, DR.REDDY'S LABORATORIES LIMITED, DR REDDYS LABORATORIES LIMITED — collectively control 77.9% of total export value, indicating a highly concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (52.2%), DR.REDDY'S LABORATORIES LTD (14.7%), FRESENIUS KABI ONCOLOGY LIMITED (4.6%), DR.REDDY'S LABORATORIES LIMITED (3.3%), DR REDDYS LABORATORIES LIMITED (3.1%).
Top Doxorubicin Exporters from India
Ranked by export value · 310 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LIMITED TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEDOXORUBICIN HYDROCHLORIDE LIPOSOME INJECDOXORUBICIN HYDROCHLORIDE LIPOSOME 50MG/ | $35.1M | 15 | 52.2% |
| 2 | DR.REDDY'S LABORATORIES LTD DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECDOXORUBICIN HCL LIPOSOME INJ 20MG/10MLDOXORUBICIN HCL LIPOSOME INJ. | $9.9M | 11 | 14.7% |
| 3 | FRESENIUS KABI ONCOLOGY LIMITED DOXORUBICIN HCL LIPOSOME INJ 20MG/10MLDOXORUBICIN HCL LIPOSOME INJ.CHEMODOX 2MG/ML, 10ML INJECTION [PACK: 1 VIAL] | $3.1M | 18 | 4.6% |
| 4 | DR.REDDY'S LABORATORIES LIMITED DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECDOXORUBICIN HCL LIPOSOME INJ 20MG/10MLDOXORUBICIN HCL LIPOSOME INJ. | $2.2M | 3 | 3.3% |
| 5 | DR REDDYS LABORATORIES LIMITED TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEDOXORUBICIN HYDROCHLORIDE LIPOSOME INJECDOXORUBICIN HCL LIPOSOME INJ 20MG/10ML | $2.1M | 2 | 3.1% |
| 6 | INTAS PHARMACEUTICALS LIMITED TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEDOXORUBICIN HYDROCHLORIDE LIPOSOME INJECLIPOSOMAL DOXORUBICIN SUN 20 MG/10 ML , 10ML) | $1.8M | 16 | 2.7% |
| 7 | EUGIA PHARMA SPECIALITIES LIMITED DOXORUBICIN HYDROCHLORIDE SOLUTION2MG/MLDOXORUBICIN HYDROCHLORIDE SOLUTION 2MG/M | $1.4M | 1 | 2.1% |
| 8 | MYLAN LABORATORIES LIMITED DOXORUBICIN HYDROCHLORIDE LIPOSOME INJEC | $1.1M | 1 | 1.7% |
| 9 | VENUS REMEDIES LIMITED DOXORUBICIN HCL LIPOSOME INJ 20MG/10MLDOXORUBICIN HCL LIPOSOME INJ.CHEMODOX 2MG/ML, 10ML INJECTION [PACK: 1 VIAL] | $1.1M | 15 | 1.6% |
| 10 | NAPROD LIFE SCIENCES PRIVATE LIMITED DOXORUBICIN 50 MG (DOXORUBICIN HYDROCHLOLIPODOX SUN 2MG/ML INJECTION 10ML [1438 PACK X 1 VIAL]VLSDOXORUBICIN 50MG(DOXORUBICIN HYDROCHLORI | $1.1M | 22 | 1.6% |
| 11 | GETWELL PHARMA INDIA PRIVATE LIMITED CHEMODOX(DOXORUBICIN HYDROCHLORIDE LIPSODOXVEX 50 (DOXORUBICIN HYDROCHLORIDE POWDACTORUBIN DOXORUBICIN AS HYDROCHLORI | $525.9K | 11 | 0.8% |
| 12 | UNITED BIOTECH PRIVATE LIMITED | $508.7K | 15 | 0.8% |
| 13 | SUN PHARMACEUTICAL INDUSTRIES LTD TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOMEDOXORUBICIN HYDROCHLORIDE LIPOSOME INJECDOXORUBICIN HYDROCHLORIDE LIPOSOME 50MG/ | $477.2K | 2 | 0.7% |
| 14 | GETWELL PHARMACEUTICALS CHEMODOX(DOXORUBICIN HYDROCHLORIDE LIPSODOXVEX 50 (DOXORUBICIN HYDROCHLORIDE POWDACTORUBIN DOXORUBICIN AS HYDROCHLORI | $352.1K | 15 | 0.5% |
| 15 | VEXXA LIFESCIENCES PVT. LTD. CHEMODOX(DOXORUBICIN HYDROCHLORIDE LIPSODOXVEX 50 (DOXORUBICIN HYDROCHLORIDE POWDACTORUBIN DOXORUBICIN AS HYDROCHLORI | $325.5K | 1 | 0.5% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Doxorubicin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES LIMITED | Approved | Yes | Yes | Multiple | Sun Pharma has received FDA approvals for various products and holds WHO-GMP and |
| DR. REDDY'S LABORATORIES LTD | Approved | Yes | Yes | Multiple | Dr. Reddy's has FDA approvals and maintains WHO-GMP and EU GMP certifications. |
| FRESENIUS KABI ONCOLOGY LIMITED | Approved | Yes | Yes | Multiple | Fresenius Kabi Oncology has FDA approvals and holds WHO-GMP and EU GMP certifica |
| INTAS PHARMACEUTICALS LIMITED | Approved | Yes | Yes | Multiple | Intas Pharmaceuticals has FDA approvals and maintains WHO-GMP and EU GMP certifi |
| MYLAN LABORATORIES LIMITED | Approved | Yes | Yes | Multiple | Mylan Laboratories has FDA approvals and holds WHO-GMP and EU GMP certifications |
| VENUS REMEDIES LIMITED | Approved | Yes | Yes | Multiple | Venus Remedies has FDA approvals and maintains WHO-GMP and EU GMP certifications |
| NAPROD LIFE SCIENCES PRIVATE LIMITED | Approved | Yes | Yes | Multiple | Naprod Life Sciences has FDA approvals and holds WHO-GMP and EU GMP certificatio |
| EUGIA PHARMA SPECIALITIES LIMITED | Approved | Yes | Yes | Multiple | Eugia Pharma Specialities has FDA approvals and maintains WHO-GMP and EU GMP cer |
| ALEMBIC PHARMACEUTICALS LIMITED | Approved | Yes | Yes | 224 | Alembic Pharmaceuticals received FDA approval for Doxorubicin Hydrochloride Lipo |
TransData Nexus reviewed the regulatory standing of 9 leading Doxorubicin exporters from India. 9 hold US FDA facility approvals, 9 maintain WHO-GMP certification, and 9 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Doxorubicin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often termed the "Bulk Drug Capital of India," is a central hub for the production of Active Pharmaceutical Ingredients (APIs). The city's pharmaceutical landscape is characterized by a robust infrastructure, a skilled workforce, and a favorable regulatory environment, making it a prime location for API manufacturing. Companies like Dr. Reddy's Laboratories Ltd., a significant exporter of Doxorubicin, have established extensive operations in this region, contributing to its prominence in the pharmaceutical sector.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its focus on pharmaceutical formulations. This region hosts numerous manufacturing units dedicated to producing finished dosage forms, including injectables and tablets. Sun Pharmaceutical Industries Limited, the leading exporter of Doxorubicin, operates substantial facilities in this area, underscoring its role as a formulations hub. The presence of such major players highlights the region's capacity for large-scale pharmaceutical production and export.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt serves as a critical export gateway for India's pharmaceutical products. Proximity to major ports like Nhava Sheva (Jawaharlal Nehru Port) facilitates efficient international distribution. Pharmaceutical companies leverage this strategic location to streamline logistics and export operations, ensuring timely delivery of products like Doxorubicin to global markets.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi-Nalagarh in Himachal Pradesh has emerged as a significant pharmaceutical manufacturing zone, primarily due to favorable tax incentives and supportive government policies. This region attracts numerous pharmaceutical companies seeking cost-effective production solutions. The conducive business environment has led to the establishment of various manufacturing units, contributing to the overall growth of India's pharmaceutical exports.
5Sourcing Recommendations
- Diversify Supplier Base: Engage with multiple suppliers across different clusters to mitigate risks associated with regional disruptions.
- Evaluate Supplier Capabilities: Assess the manufacturing capacities and compliance standards of potential suppliers to ensure consistent quality and supply.
- Leverage Export Infrastructure: Utilize suppliers with proximity to major export hubs like Mumbai to facilitate efficient logistics and reduce lead times.
- Monitor Regulatory Compliance: Ensure that suppliers adhere to international regulatory standards, such as those set by the US FDA and EMA, to maintain product integrity and market access.
By strategically sourcing from India's specialized pharmaceutical clusters, companies can optimize their supply chains for Doxorubicin, ensuring reliability and quality in their procurement processes.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Doxorubicin exporters from India
SUN PHARMACEUTICAL INDUSTRIES LIMITED — CDSCO flags Sun Pharma's Rosuvas 10 tablet as spurious
The Central Drugs Standard Control Organisation (CDSCO) identified a batch of Rosuvas 10 tablets as spurious. Sun Pharma stated that the flagged batch was counterfeit and not manufactured by them. - IMPACT: Potential reputational impact; no direct effect on Doxorubicin exports.
Impact: Potential reputational impact; no direct effect on Doxorubicin exports.
Common Questions — Doxorubicin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which doxorubicin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 149 recorded shipments worth $35.1M. DR.REDDY'S LABORATORIES LTD (51 shipments) and FRESENIUS KABI ONCOLOGY LIMITED (143 shipments) are also established high-volume exporters.
Q How many doxorubicin manufacturers are there in India?
India has 310 active doxorubicin exporters with a combined export market of $67.3M across 3,492 shipments to 136 countries. The top 5 suppliers hold 77.9% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for doxorubicin from India?
Average FOB unit price: $18.29 per unit, ranging from $0.01 to $3258.61. Average shipment value: $19.3K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 310 verified Indian exporters of Doxorubicin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 3,492 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 136 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
3,492 Verified Shipments
310 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists